PMAIP1 and ovarian neoplasm: In contrast, we recorded a trend towards decreased levels of NOXA serum protein in patients with more aggressive forms of ovarian tumors; however, this decrease did not achieve statistical significance (p = 0.9, 0.2, 0.2, respectively) (Fig. 4d, e, f).